-
45 votes
-
Why don’t we know how antidepressants work yet?
30 votes -
Ozempic and Wegovy linked to rare blindness risk, study finds
27 votes -
Collecting sex-crazed zombie cicadas on speed: Scientists track a bug-controlling super-sized fungus
24 votes -
mRNA cancer vaccine reprograms immune system to tackle glioblastoma
12 votes -
Lemon-scented marijuana compound reduces weed’s ‘paranoia’ effect
17 votes -
The hazy evolution of cannabis
3 votes -
Psilocybin therapy alters prefrontal and limbic brain circuitry in alcohol use disorder
17 votes -
AstraZeneca unveils successes in treatment of lung cancer – best-selling Tagrisso drug slows progression of most common form of the disease at an early stage
22 votes -
Researchers find response to ketamine depends on opioid pathways, but varies by sex
10 votes -
The business of bad medicine
4 votes -
Denmark is building on the success of blockbuster drugs – the country's focus on reinvestment is feeding a stream of discovery
7 votes -
New vaccine technology could protect from future viruses and variants
The vaccine antigen technology, developed by the University of Cambridge and spin-out DIOSynVax in early 2020, provided protection against all known variants of SARS-CoV-2 – the virus that causes...
The vaccine antigen technology, developed by the University of Cambridge and spin-out DIOSynVax in early 2020, provided protection against all known variants of SARS-CoV-2 – the virus that causes COVID-19 – as well as other major coronaviruses, including those that caused the first SARS epidemic in 2002.
The studies in mice, rabbits and guinea pigs [...] found that the vaccine candidate provided a strong immune response against a range of coronaviruses by targeting the parts of the virus that are required for replication.
Professor Jonathan Heeney from Cambridge’s Department of Veterinary Medicine, who led the research, [said] “We wanted to come up with a vaccine that wouldn’t only protect against SARS-CoV-2, but all its relatives.”
18 votes -
Anti-COVID drug may have led to virus mutations: study
10 votes -
Golden age of medicine
18 votes -
Alzheimer’s drug gets FDA panel’s backing, setting the stage for broader US use
13 votes -
How Sweden and Denmark became rare bright spots for Europe's pharma industry
3 votes -
The weed influencer and the scientist feuding over why some stoners incessantly puke
10 votes -
Dual use of artificial-intelligence-powered drug discovery
5 votes -
Meth addiction in fish poses threat to ecosystem balance, study says
7 votes -
How mRNA technology could change the world
8 votes -
Microdosing's feel-good benefits might just be placebo effect
18 votes -
Breakthrough male contraceptive pill derived from Chinese medicine
17 votes -
An archaeology of marijuana
10 votes -
Low doses of LSD have been found to increase pain tolerance comparable to oxycodone or morphine
4 votes -
New techniques are helping medical researchers develop new anti-cancer drugs and gain a better understanding of how existing ones work
5 votes -
Chloroquine, past and present
3 votes -
Research identifies new route for tackling drug resistance in skin cancer cells
4 votes -
The entropic brain: A theory of conscious states informed by neuroimaging research with psychedelic drugs
10 votes -
Self-blinding microdosing study, open to participation
4 votes -
Alarming surge in drug-resistant HIV uncovered
12 votes -
Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study
4 votes -
Pfizer had clues its blockbuster drug could prevent Alzheimer’s. Why didn’t it tell the world?
8 votes -
A definitive guide to the power of psychedelics -- tripping through time
5 votes -
Ketamine may relieve depression by repairing damaged brain circuits
12 votes -
A mysterious infection, spanning the globe in a climate of secrecy
6 votes -
The drugs don’t work: What happens after antibiotics?
8 votes -
New pill can deliver insulin
7 votes -
The million-dollar drug: How a Canadian medical breakthrough that was thirty years in the making became the world’s most expensive drug — and then quickly disappeared
19 votes -
What if the placebo effect isn’t a trick?
9 votes -
Hopkins researchers recommend reclassifying psilocybin, the drug in 'magic' mushrooms, from schedule I to schedule IV
9 votes -
First ever trials on the effects of microdosing LSD set to begin
19 votes -
DMT Models the Near-Death Experience
4 votes -
Pain control: “no evidence” cannabis improves outcomes
6 votes -
US FDA approves first drug designed to prevent migraines
7 votes